|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
c876774a-57f8-441f-802f-f9792e592235 |
| 005 |
20240705000000.0 |
| 008 |
870722s1987 nyua b 001 0 eng d |
| 010 |
|
|
|a 86042899
|
| 020 |
|
|
|a 0881673641
|
| 020 |
|
|
|z 0881673671
|
| 035 |
|
|
|a (OCoLC)16581986
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|
| 050 |
0 |
0 |
|a RC271.I45
|b P75 1987
|
| 060 |
|
0 |
|a QV 266 P957
|
| 082 |
0 |
|
|a 616.99/4061
|2 19
|
| 245 |
0 |
0 |
|a Principles of cancer biotherapy /
|c editor, Robert K. Oldham.
|
| 260 |
|
|
|a New York :
|b Raven Press,
|c ©1987.
|
| 300 |
|
|
|a x, 502 pages :
|b illustrations ;
|c 26 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographies and index.
|
| 650 |
|
0 |
|a Cancer
|x Immunotherapy
|
| 650 |
|
0 |
|a Biological response modifiers
|
| 650 |
|
0 |
|a Biological products
|x Therapeutic use
|
| 650 |
|
2 |
|a Antineoplastic Agents
|x therapeutic use
|
| 650 |
|
2 |
|a Biological Products
|x therapeutic use
|
| 650 |
|
2 |
|a Immunotherapy
|
| 650 |
|
2 |
|a Neoplasms
|x immunology
|
| 650 |
|
2 |
|a Neoplasms
|x therapy
|
| 700 |
1 |
|
|a Oldham, Robert K.
|
| 740 |
0 |
|
|a Cancer biotherapy.
|
| 999 |
1 |
0 |
|i c876774a-57f8-441f-802f-f9792e592235
|l 9921235030001701
|s US-MNU
|m principles_of_cancer_biotherapy____________________________________________1987_______ravena___________________________________________________________________________p
|
| 999 |
1 |
1 |
|l 9921235030001701
|s ISIL:US-MNU
|i University of Minnesota
|t BKS
|a TBIOMGENS
|c QV269 P957 1987
|d NLM
|b 31951000397305H
|x BOOK
|y 23344052650001701
|p LOANABLE
|